)
Edge11 Sep 2026
Texas Pacific Land Corporation: Keeper of the Permian Basin
Land once granted to a failed 19th-century railroad now generates royalties for Texas Pacific Land Corporation across the Permian Basin.
Bloomage BioTechnology
Bloomage BioTechnology (688363) investor relations material
Bloomage BioTechnology Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2026 earnings summary27 Aug, 2026
Executive summary
Revenue for H1 2026 was RMB 1.76 billion, down 22.32% year-over-year, mainly due to a decline in skin science innovation business income.
Net profit attributable to shareholders was RMB 153 million, a decrease of 30.82% year-over-year.
Gross margin remained high at 67.96%.
The company continued to invest in R&D, with R&D expenses accounting for 12.07% of revenue.
Strategic focus on AI and synthetic biology, with significant progress in digital transformation and product innovation.
Financial highlights
Operating income: RMB 1,756 million, down 22.32% year-over-year.
Net profit: RMB 153 million, down 30.82% year-over-year.
Operating cash flow: RMB 524 million, up 140.08% year-over-year.
Basic and diluted EPS: RMB 0.32, down 30.43% year-over-year.
Net assets attributable to shareholders: RMB 7,090 million, up 0.07% from year-end 2025.
Total assets: RMB 8,881 million, up 2.17% from year-end 2025.
Outlook and guidance
The company is focused on quality growth, digital transformation, and expanding its global presence.
Continued investment in R&D and AI-driven innovation expected to drive future growth.
Management expects ongoing challenges from international market volatility and domestic demand recovery.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Bloomage BioTechnology
- Revenue and profit fell, but cash flow improved as strategic transformation accelerates.688363
Q1 2026 - Net profit jumped 67.59% despite a 21.82% revenue drop, driven by margin and cost improvements.688363Q4 2025
- Q3 net profit surged 55.63% year-over-year as operational quality and cash flow improved.688363Q3 2025
- Revenue and net profit declined sharply, but R&D and core margins remained strong.688363Q2 2025
- Q3 net profit plunged 77% year-over-year on lower sales and higher expenses.688363Q3 2024
- H1 2024 saw profit decline but strong growth in medical terminals and raw materials.688363Q2 2024
- Q1 profit fell 58% on weak skin science sales; strategic upgrades and R&D investment continue.688363Q1 2025
- Revenue and profit fell sharply amid strategic transformation and increased costs.688363Q4 2024
Next Bloomage BioTechnology earnings date
Q3 202629 Oct, 2026
Bloomage BioTechnology
Next Bloomage BioTechnology earnings date
Q3 202629 Oct, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage